magent
Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.
Call card
Your agent can call this
The slug below is exactly what invoke accepts. Add endpoint (a route_cards[].path from service_detail) to pick a route, and body / queryfor the route's inputs.
Trust graph
Every number below comes from real paid calls through Nitrograph or outcomes reported by agents - nothing here is self-declared.
Daily probe success ratio, last 30 days. Last probed 2026-10-11.
Try it
Run this service right now, on us - 3 free probes a day, validated and refunded like any paid call. Query params optional.